Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 4835 | 4.31 |
09:34 ET | 1300 | 4.22 |
09:38 ET | 282 | 4.23 |
09:39 ET | 185 | 4.23 |
09:45 ET | 237 | 4.26 |
09:50 ET | 1000 | 4.26 |
09:54 ET | 11019 | 4.275 |
09:57 ET | 306 | 4.26 |
09:59 ET | 2990 | 4.27 |
10:01 ET | 542 | 4.25 |
10:03 ET | 100 | 4.25 |
10:06 ET | 300 | 4.25 |
10:14 ET | 100 | 4.245 |
10:15 ET | 1098 | 4.245 |
10:17 ET | 1088 | 4.2685 |
10:19 ET | 962 | 4.24 |
10:24 ET | 1400 | 4.24 |
10:26 ET | 3300 | 4.245 |
10:28 ET | 100 | 4.245 |
10:30 ET | 1201 | 4.22 |
10:32 ET | 1319 | 4.205 |
10:33 ET | 500 | 4.205 |
10:35 ET | 200 | 4.205 |
10:37 ET | 1100 | 4.19 |
10:39 ET | 4156 | 4.195 |
10:42 ET | 250 | 4.2 |
10:44 ET | 2581 | 4.205 |
10:46 ET | 900 | 4.205 |
10:48 ET | 1944 | 4.21 |
10:50 ET | 4561 | 4.225 |
10:51 ET | 1066 | 4.245 |
10:53 ET | 5647 | 4.255 |
10:55 ET | 200 | 4.255 |
10:57 ET | 500 | 4.25 |
11:00 ET | 1433 | 4.24 |
11:02 ET | 2939 | 4.21 |
11:04 ET | 433 | 4.22 |
11:06 ET | 1928 | 4.205 |
11:08 ET | 717 | 4.2075 |
11:09 ET | 400 | 4.205 |
11:11 ET | 1800 | 4.205 |
11:13 ET | 400 | 4.205 |
11:15 ET | 2603 | 4.22 |
11:20 ET | 600 | 4.23 |
11:22 ET | 200 | 4.225 |
11:24 ET | 419 | 4.225 |
11:26 ET | 100 | 4.23 |
11:27 ET | 25021 | 4.205 |
11:29 ET | 261 | 4.2 |
11:31 ET | 2557 | 4.23 |
11:33 ET | 1138 | 4.23 |
11:36 ET | 400 | 4.22 |
11:38 ET | 765 | 4.2 |
11:40 ET | 10717 | 4.21 |
11:42 ET | 600 | 4.2 |
11:44 ET | 278 | 4.195 |
11:45 ET | 603 | 4.185 |
11:47 ET | 600 | 4.18 |
11:49 ET | 9404 | 4.185 |
11:51 ET | 1762 | 4.2 |
11:54 ET | 200 | 4.205 |
11:56 ET | 200 | 4.205 |
11:58 ET | 400 | 4.205 |
12:00 ET | 500 | 4.205 |
12:02 ET | 20451 | 4.26 |
12:03 ET | 498 | 4.265 |
12:05 ET | 2059 | 4.255 |
12:07 ET | 2127 | 4.245 |
12:09 ET | 776 | 4.25 |
12:14 ET | 2497 | 4.24 |
12:18 ET | 100 | 4.24 |
12:20 ET | 2972 | 4.25 |
12:21 ET | 2392 | 4.25 |
12:23 ET | 1686 | 4.25 |
12:25 ET | 958 | 4.25 |
12:27 ET | 650 | 4.25 |
12:30 ET | 6286 | 4.26 |
12:32 ET | 310 | 4.28 |
12:34 ET | 200 | 4.27 |
12:36 ET | 100 | 4.28 |
12:38 ET | 500 | 4.27 |
12:39 ET | 13803 | 4.34 |
12:41 ET | 2720 | 4.3101 |
12:43 ET | 200 | 4.31 |
12:45 ET | 300 | 4.295 |
12:48 ET | 600 | 4.295 |
12:50 ET | 10550 | 4.31 |
12:52 ET | 176 | 4.33 |
12:54 ET | 669 | 4.325 |
12:56 ET | 1517 | 4.31 |
12:57 ET | 508 | 4.3 |
12:59 ET | 1250 | 4.29 |
01:06 ET | 400 | 4.29 |
01:08 ET | 2300 | 4.295 |
01:10 ET | 1700 | 4.32 |
01:12 ET | 200 | 4.32 |
01:14 ET | 100 | 4.315 |
01:15 ET | 2406 | 4.29 |
01:17 ET | 2171 | 4.285 |
01:19 ET | 100 | 4.29 |
01:21 ET | 1000 | 4.28 |
01:24 ET | 900 | 4.28 |
01:26 ET | 1000 | 4.27 |
01:28 ET | 489 | 4.28 |
01:30 ET | 300 | 4.28 |
01:32 ET | 1400 | 4.29 |
01:33 ET | 1000 | 4.28 |
01:35 ET | 1800 | 4.27 |
01:37 ET | 400 | 4.28 |
01:39 ET | 1101 | 4.28 |
01:42 ET | 700 | 4.28 |
01:44 ET | 800 | 4.28 |
01:46 ET | 2274 | 4.27 |
01:48 ET | 2464 | 4.255 |
01:50 ET | 1619 | 4.245 |
01:51 ET | 1474 | 4.245 |
01:53 ET | 400 | 4.245 |
01:55 ET | 600 | 4.24 |
01:57 ET | 300 | 4.25 |
02:00 ET | 2132 | 4.235 |
02:02 ET | 200 | 4.235 |
02:04 ET | 2512 | 4.225 |
02:06 ET | 2386 | 4.235 |
02:08 ET | 933 | 4.25 |
02:09 ET | 3100 | 4.25 |
02:11 ET | 3100 | 4.235 |
02:13 ET | 1062 | 4.235 |
02:15 ET | 200 | 4.24 |
02:18 ET | 800 | 4.235 |
02:20 ET | 499 | 4.239 |
02:22 ET | 600 | 4.24 |
02:24 ET | 900 | 4.235 |
02:26 ET | 2019 | 4.24 |
02:27 ET | 1000 | 4.25 |
02:29 ET | 1059 | 4.249 |
02:31 ET | 4959 | 4.235 |
02:33 ET | 100 | 4.235 |
02:36 ET | 2312 | 4.2 |
02:38 ET | 100 | 4.21 |
02:40 ET | 500 | 4.215 |
02:42 ET | 1317 | 4.225 |
02:44 ET | 1279 | 4.23 |
02:45 ET | 600 | 4.23 |
02:47 ET | 1861 | 4.22 |
02:49 ET | 270 | 4.215 |
02:51 ET | 400 | 4.215 |
02:54 ET | 700 | 4.215 |
02:56 ET | 1200 | 4.229 |
02:58 ET | 1863 | 4.229 |
03:00 ET | 2106 | 4.22 |
03:02 ET | 400 | 4.215 |
03:03 ET | 589 | 4.21 |
03:05 ET | 100 | 4.22 |
03:07 ET | 625 | 4.22 |
03:09 ET | 2230 | 4.22 |
03:12 ET | 800 | 4.22 |
03:14 ET | 1100 | 4.225 |
03:16 ET | 700 | 4.225 |
03:18 ET | 3180 | 4.205 |
03:20 ET | 1424 | 4.215 |
03:21 ET | 900 | 4.215 |
03:23 ET | 1000 | 4.215 |
03:25 ET | 4070 | 4.2 |
03:27 ET | 1264 | 4.22 |
03:30 ET | 1818 | 4.205 |
03:32 ET | 31294 | 4.185 |
03:34 ET | 1407 | 4.175 |
03:36 ET | 700 | 4.18 |
03:38 ET | 800 | 4.175 |
03:39 ET | 1100 | 4.175 |
03:41 ET | 1600 | 4.175 |
03:43 ET | 2780 | 4.1699 |
03:45 ET | 33111 | 4.1964 |
03:48 ET | 32184 | 4.165 |
03:50 ET | 5747 | 4.17 |
03:52 ET | 3119 | 4.175 |
03:54 ET | 7200 | 4.18 |
03:56 ET | 7757 | 4.195 |
03:57 ET | 10824 | 4.19 |
03:59 ET | 14096 | 4.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 478.8M | -2.2x | --- |
Verve Therapeutics Inc | 502.1M | -2.1x | --- |
Ocugen Inc | 491.5M | -8.1x | --- |
Adlai Nortye Ltd | 488.9M | -1.8x | --- |
Fulcrum Therapeutics Inc | 469.3M | -4.7x | --- |
Corbus Pharmaceuticals Holdings Inc | 480.9M | -6.5x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $478.8M |
---|---|
Revenue (TTM) | $-477.0K |
Shares Outstanding | 114.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.87 |
EPS | $-1.91 |
Book Value | $-0.20 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.